European Union · regulation

Commission Regulation (EU) 2021/644 of 15 April 2021 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for fluxapyroxad, hymexazol, metamitron, penflufen and spirotetramat in or on certain products (Text with EEA relevance)

EU law (EUR-Lex)
View original document

The full text is hosted by the publishing organisation. lawenc.com indexes the metadata and links to the official source.

Key facts
Organisation European Union
Document type regulation
Adoption date
Source EU law (EUR-Lex)